Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,620 | -67,117 | -47,995 | -25,016 | -98,426 |
| Depreciation Amortization | -1,493 | -685 | 367 | 281 | 800 |
| Accounts payable and accrued liabilities | -2,475 | -2,809 | -1,458 | -629 | 846 |
| Other Working Capital | -32,266 | -24,147 | -18,913 | -9,253 | -41,879 |
| Other Operating Activity | 22,448 | 18,871 | 13,117 | 5,272 | 20,553 |
| Operating Cash Flow | $-100,406 | $-75,887 | $-54,882 | $-29,345 | $-118,106 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -261,470 | -221,821 | -97,367 | -31,263 | -73,901 |
| PPE Investments | -906 | -427 | -118 | -101 | -1,224 |
| Purchase Of Investment | 232,472 | 170,053 | 106,605 | 58,459 | 219,575 |
| Investing Cash Flow | $-29,904 | $-52,195 | $9,120 | $27,095 | $144,450 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 106,013 | 106,009 | 104,568 | 1,167 | 1,778 |
| Other Financing Activity | -585 | -585 | -195 | 0 | 0 |
| Financing Cash Flow | $105,428 | $105,424 | $104,373 | $1,167 | $1,778 |
| Beginning Cash Position | 82,044 | 82,044 | 82,044 | 82,044 | 53,922 |
| End Cash Position | 57,162 | 59,386 | 140,655 | 80,961 | 82,044 |
| Net Cash Flow | $-24,882 | $-22,658 | $58,611 | $-1,083 | $28,122 |
| Free Cash Flow | |||||
| Operating Cash Flow | -100,406 | -75,887 | -54,882 | -29,345 | -118,106 |
| Capital Expenditure | -906 | -427 | -118 | -101 | -1,224 |
| Free Cash Flow | -101,312 | -76,314 | -55,000 | -29,446 | -119,330 |